The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Study acronym: ACT
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv21
  2. Site contact updatedv20
  3. Re-verified, no change to tracked fieldsv19
  4. Eligibility criteria expanded, about 19 words
    • Study title expanded, about 8 words
    • Collaborators shortened, about 5 words
    v18
  5. Lead sponsor: Medical University of South Carolina to University of Florida
    • Study site revised
    • Collaborator revised
    v17
Show 15 earlier versionsHide 15 earlier versions
  1. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v16
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v15
  3. 5 versions Re-verified since Apr 17, 2015, no change to tracked fieldsv10-v14
  4. Publications: 4 to 7v9
  5. Re-verified, no change to tracked fieldsv8
  6. Phase: Not applicable to Not specifiedv7 Show 6 more changesShow less
    • Enrollment target: 25000 to 50000
    • Eligibility criteria expanded, about 12 words
    • Study description expanded, about 9 words
    • Publications: 3 to 4
    • Collaborators expanded, about 3 words
    • Study title shortened, about 2 words
  7. 3 versions Re-verified since Feb 12, 2009, no change to tracked fieldsv4-v6
  8. Primary completion date: Jan 2050v3
  9. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.
Trial Details
NCT Number NCT00500123
Lead Sponsor University of Florida
Conditions
(from sponsor)		 Alpha-1 Antitrypsin Deficiency
Related terms alpha 1-Antitrypsin Deficiency
Enrollment 50,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov